乳腺癌-话题@MedSci

#乳腺癌#

280篇内容 | 10048人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=808660, encodeId=579780866032, content=<a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a>的研究越来越细分，关注到一些细分人群。如<a href='/topic/show?id=d2d2103e8909' target=_blank style='color:#2F92EE;'>#三阳性乳腺癌#</a><a href='/topic/show?id=b94a103e903e' target=_blank style='color:#2F92EE;'>#HR+HER2+#</a>，或<a href='/topic/show?id=3f6c103e916d' target=_blank style='color:#2F92EE;'>#ER+PR-乳腺癌#</a>或<a href='/topic/show?id=0d70103e92d3' target=_blank style='color:#2F92EE;'>#AR+三阴性乳腺癌#</a>等等，这些都值得同道关注, objectTitle=三阳性乳腺癌，抗HER2联合化疗，还是联合内分泌治疗？, objectType=article, longId=198990, objectId=55ce1989908b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/408.jpg, objectUrl=/article/show_article.do?id=55ce1989908b, replyNumber=0, likeNumber=2, createdTime=2020-08-13, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55ce1989908b, moduleTitle=三阳性乳腺癌，抗HER2联合化疗，还是联合内分泌治疗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55ce1989908b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=808655, encodeId=a132808655ba, content=<a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a>BRCA1/2突变，用<a href='/topic/show?id=41f54454653' target=_blank style='color:#2F92EE;'>#奥拉帕利#</a>很合时宜，但是用PD-L1，是值得怀疑的，对于这样明确突变的人群，很少看到PD-1、或PD-L1获益的。在肺癌中EGFR突变的患者，原则上不宜用免疫治疗的。, objectTitle=Lancet oncol：奥拉帕利联合Durvalumab治疗BRCA突变的转移性乳腺癌, objectType=article, longId=199142, objectId=daaa19914221, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/193.jpg, objectUrl=/article/show_article.do?id=daaa19914221, replyNumber=0, likeNumber=182, createdTime=2020-08-13, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=daaa19914221, moduleTitle=Lancet oncol：奥拉帕利联合Durvalumab治疗BRCA突变的转移性乳腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=daaa19914221)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=808397, encodeId=1cbf80839ea8, content=广大乳癌患者**<a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a>, objectTitle=TUKYSA（tucatinib）在澳大利亚获得批准，用于治疗转移性HER2阳性乳腺癌, objectType=article, longId=199343, objectId=af9d1993432d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020812/1597244632127_5295902.jpeg, objectUrl=/article/show_article.do?id=af9d1993432d, replyNumber=0, likeNumber=140, createdTime=2020-08-13, rootId=0, userName=Psycho.Dr Du, userId=a8fb2299762, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af9d1993432d, moduleTitle=TUKYSA（tucatinib）在澳大利亚获得批准，用于治疗转移性HER2阳性乳腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af9d1993432d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=803728, encodeId=9842803e28d8, content=<a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a>与心血管千丝万缕, objectTitle=Nat Med：警惕！心血管疾病会加速乳腺癌复发, objectType=article, longId=197893, objectId=82c619e893b6, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020721/1595332387083_5295905.jpg, objectUrl=/article/show_article.do?id=82c619e893b6, replyNumber=0, likeNumber=161, createdTime=2020-07-21, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=82c619e893b6, moduleTitle=Nat Med：警惕！心血管疾病会加速乳腺癌复发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=82c619e893b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=803351, encodeId=71b2803351ff, content=<a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a>, objectTitle=李青：乳腺癌靶向治疗及进展, objectType=video, longId=4270, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://medsci-video.oss-cn-shanghai.aliyuncs.com/upload/content/day_181113/big/201811132053108218.png, objectUrl=null, replyNumber=0, likeNumber=105, createdTime=2020-07-19, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a91ef442e0654, moduleTitle=李青：乳腺癌靶向治疗及进展, moduleType=video, hrefUrl=)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=803283, encodeId=b4b880328301, content=<a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a>禁食治疗, objectTitle=NATURE：饮食限制配合激素治疗可长效促进乳腺癌消退, objectType=article, longId=197754, objectId=2e1e19e75487, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020719/1595129006994_5295900.jpg, objectUrl=/article/show_article.do?id=2e1e19e75487, replyNumber=0, likeNumber=142, createdTime=2020-07-19, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e1e19e75487, moduleTitle=NATURE：饮食限制配合激素治疗可长效促进乳腺癌消退, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e1e19e75487)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=803070, encodeId=501c8030e01c, content=<a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a>与心梗关联起来了, objectTitle=Nat Med：心脏病或促进乳腺癌转移！心脏病会重编程免疫系统，导致免疫力下降，促进乳腺癌进展和转移, objectType=article, longId=197655, objectId=0de419e655aa, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20200716/765a34313bd749d3b810e4e36265c74c.jpg, objectUrl=/article/show_article.do?id=0de419e655aa, replyNumber=0, likeNumber=145, createdTime=2020-07-17, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0de419e655aa, moduleTitle=Nat Med：心脏病或促进乳腺癌转移！心脏病会重编程免疫系统，导致免疫力下降，促进乳腺癌进展和转移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0de419e655aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=802351, encodeId=fdd48023511c, content=<a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a>卵巢功能抑制的分析，这里面算是大全呢, objectTitle=乳腺癌卵巢功能抑制(OFS) 在乳腺癌中是是非非, objectType=article, longId=197345, objectId=aea719e3451b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20200709/6e4d5796a67e4585a05b59ff73212345.jpg, objectUrl=/article/show_article.do?id=aea719e3451b, replyNumber=0, likeNumber=168, createdTime=2020-07-10, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aea719e3451b, moduleTitle=乳腺癌卵巢功能抑制(OFS) 在乳腺癌中是是非非, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aea719e3451b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=800726, encodeId=f12c800e26a1, content=<a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a>双妥方案皮下使用, objectTitle=FDA批准罗氏的乳腺癌双靶向HER2抗体组合：帕妥珠单抗与曲妥珠单抗, objectType=article, longId=196865, objectId=2899196865f2, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202071/1593555684130_5085975.jpg, objectUrl=/article/show_article.do?id=2899196865f2, replyNumber=0, likeNumber=136, createdTime=2020-07-01, rootId=0, userName=mswert122, userId=2a791737770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2899196865f2, moduleTitle=FDA批准罗氏的乳腺癌双靶向HER2抗体组合：帕妥珠单抗与曲妥珠单抗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2899196865f2)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=799797, encodeId=3860e997977e, content=<a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a>乳腺肿瘤发展还是很迅速的，希望在三阴乳腺也有突破。, objectTitle=Pre-ASCO 乳腺癌治疗的现状与未来, objectType=video, longId=4487, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://medsci-video.oss-cn-shanghai.aliyuncs.com/upload/content/day_200528/big/202005281532575595.png, objectUrl=null, replyNumber=0, likeNumber=80, createdTime=2020-06-25, rootId=0, userName=mswert122, userId=2a791737770, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a0c97f448e8d5, moduleTitle=Pre-ASCO 乳腺癌治疗的现状与未来, moduleType=video, hrefUrl=)], followStatus=false, userIsMember=true, type=1, lengthMark=0)] 梅斯话题小助手

让乳腺癌成为不会危及生命的慢病！

2020-05-29

lovetcm (审核中...)

前往app查看评论内容

#乳腺癌#的研究越来越细分，关注到一些细分人群。如#三阳性乳腺癌##HR+HER2+#，或#ER+PR-乳腺癌#或#AR+三阴性乳腺癌#等等，这些都值得同道关注

三阳性乳腺癌，抗HER2联合化疗，还是联合内分泌治疗？

2020-08-13

lovetcm (审核中...)

前往app查看评论内容

#乳腺癌#BRCA1/2突变，用#奥拉帕利#很合时宜，但是用PD-L1，是值得怀疑的，对于这样明确突变的人群，很少看到PD-1、或PD-L1获益的。在肺癌中EGFR突变的患者，原则上不宜用免疫治疗的。

Lancet oncol：奥拉帕利联合Durvalumab治疗BRCA突变的转移性乳腺癌

2020-08-13

Psycho.Dr Du (审核中...)

前往app查看评论内容

广大乳癌患者**#乳腺癌#

TUKYSA（tucatinib）在澳大利亚获得批准，用于治疗转移性HER2阳性乳腺癌

2020-08-13

lovetcm (审核中...)

前往app查看评论内容

#乳腺癌#与心血管千丝万缕

Nat Med：警惕！心血管疾病会加速乳腺癌复发

2020-07-21

lovetcm (审核中...)

前往app查看评论内容

#乳腺癌#

李青：乳腺癌靶向治疗及进展

2020-07-19

lovetcm (审核中...)

前往app查看评论内容

#乳腺癌#禁食治疗

NATURE：饮食限制配合激素治疗可长效促进乳腺癌消退

2020-07-19

lovetcm (审核中...)

前往app查看评论内容

#乳腺癌#与心梗关联起来了

Nat Med：心脏病或促进乳腺癌转移！心脏病会重编程免疫系统，导致免疫力下降，促进乳腺癌进展和转移

2020-07-17

lovetcm (审核中...)

前往app查看评论内容

#乳腺癌#卵巢功能抑制的分析，这里面算是大全呢

乳腺癌卵巢功能抑制(OFS) 在乳腺癌中是是非非

2020-07-10

(审核中...)

前往app查看评论内容

#乳腺癌#双妥方案皮下使用

FDA批准罗氏的乳腺癌双靶向HER2抗体组合：帕妥珠单抗与曲妥珠单抗

2020-07-01

(审核中...)

前往app查看评论内容

#乳腺癌#乳腺肿瘤发展还是很迅速的，希望在三阴乳腺也有突破。

Pre-ASCO 乳腺癌治疗的现状与未来

2020-06-25

科室
- - 订阅+
  - 更多科室
工具
服务